| ABCG2 | ATP-binding cassette transporter 2 |
| AGXT2 | Alanine-Glyoxylate Aminotransferase 2 |
| CCNH | Cyclin-H |
| CCM | Corneal confocal microscopy |
| CIPN | Chemotherapy-Induced Peripheral Neuropathy |
| CRC | Colorectal Cancer |
| CMAP | Motor action compound potential |
| CSA | Cross-sectional area |
| CT | Computed Tomography |
| DRG | Dorsal root ganglia |
| ERCC1 | Excision Repair 1, Endonuclease Non-Catalytic Subunit |
| FARS:2 | Phenylalanyl-tRNA synthase 2 |
| FOLFOX | Folinic acid, 5-fluorouracil, and oxaliplatin |
| FOLFIRINOX | Fluorouracil leucovorin irinotecan oxaliplatin |
| GSTP1 | Glutathione-S-transferase P1 |
| GSTM1 | Glutathione-S-transferase M1 |
| GSTT1 | Glutathione-S-transferase T1 |
| GWAS | Genome wide analysis studies |
| HRUS | High-resolution ultrasound |
| IENF | Intraepidermal nerve fiber |
| KCCN3 | Voltage-gated potassium channels |
| MRN | Magnetic resonance neurography |
| NCI-CTCAE | Common Terminology Criteria for Adverse Events from the National Cancer Institute |
| NCS | Nerve Conduction Studies |
| NGF | Nerve Growth Factor |
| NfL | Neurofilament light chain |
| OXA | Oxaliplatin |
| OXAIPN | Oxaliplatin-induced peripheral neurotoxicity |
| QST | Quantitative Sensory Testing |
| ROS | Reactive oxygen species |
| SCNA | Voltage-gated sodium channels |
| SNP | Single nucleotide polymorphism |
| SNAP | Sensory nerve action potential |
| XELOX | capecitabine and oxaliplatin |
| XRCC:1 | X-ray repair cross-complementing protein 1 |